Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Thyroid Hormone Analog Therapy of Patients With Severe Psychomotor Retardation Caused by Mutations in the MCT8 Thyroid Hormone Transporter: The Triac Trial.

NCT02060474 is registered in ClinicalTrials.gov with Erasmus Medical Center as lead sponsor.

NCT NCT02060474
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02060474 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Thyroid Hormone Analog Therapy of Patients With Severe Psychomotor Retardation Caused by Mutations in the MCT8 Thyroid Hormone Transporter: The Triac Trial.
Lead sponsor
Erasmus Medical Center
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2014
Completion date
June 26, 2018
Enrollment
46 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

allan-herndon-dudley syndrome